Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 50 positions · Total reported value $977.84M · Top-10 concentration 61.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, Logos Global Management LP disclosed 50 equity positions with a combined reported value of $977.84M. The filing implies a focused portfolio: its ten largest positions account for 61.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were CYTK ($135.67M), SRPT ($67.50M), IDYA ($64.04M). By sector, the heaviest allocations are Health Care 75.3%, Other 24.7%. Versus the prior quarter, allocation shifted toward Health Care (+3.9pp) and away from Other (-3.9pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 45% of names.

The largest new positions opened in Q4 2023 were ARGX ($55.16M), RYZB ($35.32M), OCUL ($17.84M).

Of the 20 positions fully exited versus the prior quarter, the largest were NBIX ($16.88M), CERE ($15.28M), ROIV ($14.02M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • ARGX ARGENX SE · $55.16M
  • RYZB RAYZEBIO INC · $35.32M
  • OCUL OCULAR THERAPEUTIX INC · $17.84M
  • EWTX EDGEWISE THERAPEUTICS INC · $10.39M
  • SLRN ACELYRIN INC · $9.32M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $9.06M
  • ATYR ATHIRA PHARMA INC · $8.25M
  • FULC FULCRUM THERAPEUTICS INC · $8.10M

Fully Exited (vs previous quarter)

  • NBIX NEUROCRINE BIOSCIENCES INC · prev qtr: $16.88M
  • CERE CEREVEL THERAPEUTICS HLDNG I · prev qtr: $15.28M
  • ROIV ROIVANT SCIENCES LTD · prev qtr: $14.02M
  • MRTX MIRATI THERAPEUTICS INC · prev qtr: $13.07M
  • IMTX IMMATICS N.V · prev qtr: $12.16M
  • BBIO BRIDGEBIO PHARMA INC · prev qtr: $10.55M
  • RYTM RHYTHM PHARMACEUTICALS INC · prev qtr: $9.17M · history
  • KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $8.67M

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 75.3%
Other 24.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.62M $135.67M 13.88%
13.88%
Add
2 700.00K $67.50M 6.90%
6.90%
Add
3 1.80M $64.04M 6.55%
6.55%
Reduce
4 950.00K $56.87M 5.82%
5.82%
Add
5 145.00K $55.16M 5.64%
5.64%
New
6 4.38M $54.38M 5.56%
5.56%
Add
7 1.20M $50.56M 5.17%
5.17%
Reduce
8 1.07M $43.62M 4.46%
4.46%
Add
9 1.27M $38.21M 3.91%
3.91%
Reduce
10 568.17K $35.32M 3.61%
3.61%
New
11 2.10M $29.90M 3.06%
3.06%
Add
12 90.00K $28.49M 2.91%
2.91%
Reduce
13 400.00K $27.33M 2.79%
2.79%
Reduce
14 1.88M $25.00M 2.56%
2.56%
Reduce
15 4.95M $22.47M 2.30%
2.30%
Reduce
16 800.00K $18.68M 1.91%
1.91%
Add
17 4.00M $17.84M 1.82%
1.82%
New
18 5.03M $13.34M 1.36%
1.36%
Hold
19 600.00K $13.07M 1.34%
1.34%
Reduce
20 950.00K $10.39M 1.06%
1.06%
New
21 350.00K $10.04M 1.03%
1.03%
Add
22 1.00M $9.90M 1.01%
1.01%
Add
23 1.25M $9.32M 0.95%
0.95%
New
24 150.00K $9.06M 0.93%
0.93%
New
25 5.85M $8.25M 0.84%
0.84%
New
26 1.00M $8.13M 0.83%
0.83%
Hold
27 1.20M $8.10M 0.83%
0.83%
New
28 2.90M $7.92M 0.81%
0.81%
Reduce
29 500.00K $7.58M 0.78%
0.78%
New
30 284.37K $7.44M 0.76%
0.76%
New
31 775.00K $7.01M 0.72%
0.72%
New
32 400.00K $6.95M 0.71%
0.71%
New
33 150.00K $6.91M 0.71%
0.71%
Reduce
34 382.35K $6.52M 0.67%
0.67%
New
35 325.00K $6.21M 0.64%
0.64%
New
36 200.00K $5.78M 0.59%
0.59%
New
37 1.66M $5.56M 0.57%
0.57%
New
38 2.00M $4.94M 0.51%
0.51%
Add
39 300.00K $4.73M 0.48%
0.48%
Reduce
40 600.00K $4.38M 0.45%
0.45%
Add
41 500.00K $4.38M 0.45%
0.45%
Reduce
42 307.08K $4.25M 0.43%
0.43%
Hold
43 544.96K $4.19M 0.43%
0.43%
Hold
44 100.00K $3.80M 0.39%
0.39%
New
45 150.00K $3.23M 0.33%
0.33%
Reduce
46 150.00K $2.63M 0.27%
0.27%
New
47 300.00K $1.25M 0.13%
0.13%
Reduce
48 493.83K $928.39K 0.10%
0.10%
Hold
49 421.18K $631.78K 0.07%
0.07%
Hold
50 66.67K $4.00K 0.00%
0.00%
Hold

FAQ

What did Logos Global Management LP buy in 2023-Q4?

In its 2023-Q4 13F filing, Logos Global Management LP reported 50 equity positions worth $977.84M in aggregate; its largest disclosed positions were CYTK ($135.67M), SRPT ($67.50M), IDYA ($64.04M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $977.84M of long equity holdings across 50 positions as of 2023-Q4. Top-10 holdings account for 61.5% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →